Mikael Jones
University of Kentucky
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mikael Jones.
Pharmacotherapy | 2004
Jeremy D. Flynn; Wendell S. Akers; Mikael Jones; Natasa Stevkovic; Thomas Waid; Timothy W. Mullett; Salik Jahania
A 61‐year‐old woman who underwent lung transplantation developed severe respiratory syncytial virus (RSV) pneumonia and experienced respiratory failure requiring mechanical ventilation. She was treated initially with aerosolized ribavirin monotherapy; RSV hyperimmune globulin was later added to her regimen. Lung transplant recipients are acutely susceptible to respiratory infections, including community‐acquired respiratory viruses. Respiratory syncytial virus is particularly difficult to treat in immunocompromised patients because of the lack of proved pharmaceutical agents and solid scientific evidence by which to guide therapy. The most important factor appears to be the early start of therapy; immunocompromised patients who develop RSV pneumonia and subsequent respiratory failure requiring mechanical ventilation have a mortality rate approaching 100%. This case report demonstrates the successful treatment of RSV pneumonia with the combination of aerosolized ribavirin and RSV hyperimmune globulin in a severely ill lung transplant recipient who required mechanical ventilation.
Pharmacy Practice (internet) | 2013
Felix K. Yam; Aimee G. Adams; Holly Divine; Douglas Steinke; Mikael Jones
Background Evidence suggests that patients with type 2 diabetes (T2DM) suffer from a high rate of “clinical inertia” or “recognition of the problem but failure to act.” Objective The aim of this study is to quantify the rate of clinical inertia between two models of care: Pharmacist-Managed Diabetes Clinic (PMDC) vs. Usual Medical Care (UMC). Methods Patients in a university based medical clinic with type 2 diabetes (T2DM) were analyzed in this retrospective cohort study. Patients were exposed to either PMDC or UMC. The difference in days to intervention in response to suboptimal laboratory values and time to achieve goal hemoglobin A1c (A1c), systolic blood pressure (SBP) and low-density lipoprotein (LDL) was compared in the two models of care. Results A total of 113 patients were included in the analysis of this study, 54 patients were in the PMDC and 59 patients were in the UMC group. Median time (days) to intervention for A1c values >7% was 8 days and 9 days in the PMDC and UMC groups, respectively (p>0.05). In patients with baseline A1c values >8%, median time to achieving A1c<7% was 259 days vs. 403 days in the PMDC and UMC groups, respectively (p<0.05). Median time to goal SBP was 124 days in the PMDC group and 532 days in the UMC group (p<0.05). Median time to goal LDL was 412 days in the PMDC group vs. 506 days in the UMC group (p<0.05). Conclusions Rates of clinical inertia, defined as time to intervention of suboptimal clinical values, did not differ significantly between patients enrolled in a PMDC compared to patients with UMC with respect to A1c, SBP and LDL. Participation in PMDC, however, was associated with achieving goal A1c, SBP, and LDL levels sooner compared to UMC.
Nurse Educator | 2016
Ashley Arentsen; Darlene Welsh; Mikael Jones; Donna Weber; Stacy Taylor; Janice Kuperstein; Mary Kay Rayens; Elizabeth Salt
A preferred format to deliver interprofessional education (IPE) has not been described. The aim of this study was to compare students’ (N = 150) perceived value and improvement in communication between an IPE activity delivered using a comprehensive versus an abbreviated format. Although both formats were perceived by students to improve their communication skills and add value to their education, students indicated the abbreviated format was more effective than the comprehensive format.
Health and Interprofessional Practice | 2015
Rosemarie L. Conigliaro; Janice Kuperstein; Darlene Welsh; Stacy Taylor; Donna Weber; Mikael Jones
Few interprofessional education (IPE) models include patients and caregivers. To address this, we developed a novel model for teaching IP communication which included patients and caregivers as team members. We describe the model and our use of it in several health professions education curricula. We report preliminary data from learners regarding their experiences learning and utilizing the model as part of their IPE. Overall the model was positively viewed by students, although the perceived value of learning activities involving the model varied by discipline. Physical therapy, nursing, and pharmacy students valued the IPE model most, whereas medical students valued it the least. Received: 05/04/2015 Accepted: 08/21/2015 Published: 10/01/2015
Journal of Interprofessional Education and Practice | 2015
Mandy Jones; Kevin M. Schuer; James Ballard; Stacy Taylor; Dominique Zephyr; Mikael Jones
MedEdPORTAL Publications | 2013
Rosemarie L. Conigliaro; Janice Kuperstein; Jennifer Dupuis; Darlene Welsh; Stacy Taylor; Donna Weber; Mikael Jones
Innovations in pharmacy | 2018
Leah Simpson; Mikael Jones; Stacy Taylor
Archive | 2013
Felix K. Yam; Aimee G. Adams; Holly Divine; Douglas T. Steinke; Mikael Jones
Archive | 2008
Jeff Cain; Eleanora R Bird; Mikael Jones
Archive | 2007
Mikael Jones; Mandy Jones; Eleanora R Bird; Frank Romanelli; Patricia R. Freeman